USP28 enables oncogenic transformation of respiratory cells and its inhibition potentiates molecular therapy targeting mutant EGFR, BRAF and PI3K
Preprint
Abstract
Oncogenic transformation of lung epithelial cells is a multi-step process, frequently starting with the inactivation of tumor suppressors and subsequent activating mutations in proto-oncogenes, such as members of the PI3K or MAPK family. Cells undergoing transformation have to adjust to changes, such as metabolic requirements. This is achieved, in part, by modulating the protein abundance of transcription factors, which manifest these adjustments. Here, we report that the deubiquitylase USP28 enables oncogenic reprogramming by regulating the protein abundance of proto-oncogenes, such as c-JUN, c-MYC, NOTCH and ΔNP63, at early stages of malignant transformation. USP28 is increased in cancer compared to normal cells due to a feed-forward loop, driven by increased amounts of oncogenic transcription factors, such as c-MYC and c-JUN. Irrespective of oncogenic driver, interference with USP28 abundance or activity suppresses growth and survival of transformed lung cells. Furthermore, inhibition of USP28 via a small molecule inhibitor reset the proteome of transformed cells towards a ‘pre-malignant’ state, and its inhibition cooperated with clinically established compounds used to target EGFR L858R , BRAF V600E or PI3K H1047R driven tumor cells. Targeting USP28 protein abundance already at an early stage via inhibition of its activity therefore is a feasible strategy for the treatment of early stage lung tumours and the observed synergism with current standard of care inhibitors holds the potential for improved targeting of established tumors.Keywords
All Related Versions
- Published version: Molecular Oncology, 16 (17), 3082.
This publication has 40 references indexed in Scilit:
- The deubiquitinase USP28 controls intestinal homeostasis and promotes colorectal cancerJournal of Clinical Investigation, 2014
- USP28 Is Recruited to Sites of DNA Damage by the Tandem BRCT Domains of 53BP1 but Plays a Minor Role in Double-Strand Break MetabolismMolecular and Cellular Biology, 2014
- Clinicopathologic and prognostic significance of c-MYC copy number gain in lung adenocarcinomasBritish Journal of Cancer, 2014
- A KRAS-directed transcriptional silencing pathway that mediates the CpG island methylator phenotypeeLife, 2014
- deltaNp63 Has a Role in Maintaining Epithelial Integrity in Airway EpitheliumPLOS ONE, 2014
- The Deubiquitinase USP28 Stabilizes LSD1 and Confers Stem-Cell-like Traits to Breast Cancer CellsCell Reports, 2013
- A Role for the Deubiquitinating Enzyme USP28 in Control of the DNA-Damage ResponseCell, 2006
- Identification of Bronchioalveolar Stem Cells in Normal Lung and Lung CancerCell, 2005
- The proteasome: a novel target for cancer chemotherapyLeukemia, 2002
- Role of macrophage-stimulating protein and its receptor, RON tyrosine kinase, in ciliary motility.Journal of Clinical Investigation, 1997